Tesamorelin Dose Calculator
Pre-filled for Tesamorelin's standard vial size. Adjust your target dose and see the exact number of units to draw on a U-100 insulin syringe.
Typical protocol: 2 mg daily (per FDA label).
FDA-approved dose is 2 mg subcutaneously once daily. IGF-1 monitoring is standard; clinically meaningful effects take 12+ weeks to develop.
Inputs
The total mg of peptide in the lyophilized vial (e.g., 5 mg).
Volume of BAC water used for reconstitution. Common: 1, 2, or 3 mL.
Desired per-injection dose.
Quick Presets
Result
Draw on U-100 syringe
40units
= 0.4 mL draw volume
Concentration
5 mg/mL
After reconstitution
Units per mg
20
On U-100 syringe
Dose
2 mg
2 mg per injection
Doses per vial
5
Approximate
Reference tool for educational purposes. Always verify calculations independently and consult a qualified medical professional before any self-administration.
Want the full Tesamorelin reference?
FDA-approved synthetic GHRH analog indicated for HIV-associated lipodystrophy, studied for visceral adipose tissue reduction and cognitive endpoints.
Read the Tesamorelin page →